Tag: Dr. Jonathan Wall


News

UTHSC’s Jonathan Wall Awarded $385,000 Grant To Study Amyloidosis Treatment Options

|

Jonathan Wall, PhD, professor in the University of Tennessee Health Science Center’s Graduate School of Medicine in Knoxville and director of the Amyloidosis and Cancer Theranostics, has been awarded a two-year grant totaling $385,000 from the National Institute on Aging, part of the National Institutes of Health to study new treatments for systemic amyloidosis. “Our… Read More


News

Researcher Jonathan Wall, PhD, with The University of Tennessee Health Science Center Receives $1 Million to Study Antibody Therapy for Systemic Amyloid Disease

|

The amyloidoses are a group of rare diseases that are a consequence of abnormal protein (amyloid) deposits in various body tissues and organs. Characterized as systemic or localized, light chain-associated amyloidosis (AL) is the most common form of systemic amyloid disease, with an estimated 4,500 new cases each year in the United States. Systemic amyloid… Read More